Fig. 2
Kaplan–Meier Estimates of Progression-free Survival among patients in the vinorelbine group and apatinib plus vinorelbine group.
Fig. 2 | npj Breast Cancer
Kaplan–Meier Estimates of Progression-free Survival among patients in the vinorelbine group and apatinib plus vinorelbine group.
